[HTML][HTML] Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets
F Shu, H Xiao, QN Li, XS Ren, ZG Liu, BW Hu… - … and Targeted Therapy, 2023 - nature.com
Autophagy is a conserved lysosomal degradation pathway where cellular components are
dynamically degraded and re-processed to maintain physical homeostasis. However, the …
dynamically degraded and re-processed to maintain physical homeostasis. However, the …
[HTML][HTML] Autophagy in Parkinson's disease
Impaired protein homeostasis and accumulation of damaged or abnormally modified protein
are common disease mechanisms in many neurodegenerative disorders, including …
are common disease mechanisms in many neurodegenerative disorders, including …
[HTML][HTML] Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities
FM Menzies, A Fleming, A Caricasole, CF Bento… - Neuron, 2017 - cell.com
Autophagy is a conserved pathway that delivers cytoplasmic contents to the lysosome for
degradation. Here we consider its roles in neuronal health and disease. We review …
degradation. Here we consider its roles in neuronal health and disease. We review …
ATP13A2 deficiency disrupts lysosomal polyamine export
S van Veen, S Martin, C Van den Haute, V Benoy… - Nature, 2020 - nature.com
Abstract ATP13A2 (PARK9) is a late endolysosomal transporter that is genetically implicated
in a spectrum of neurodegenerative disorders, including Kufor-Rakeb syndrome—a …
in a spectrum of neurodegenerative disorders, including Kufor-Rakeb syndrome—a …
Defects in trafficking bridge Parkinson's disease pathology and genetics
A Abeliovich, AD Gitler - Nature, 2016 - nature.com
Parkinson's disease is a debilitating, age-associated movement disorder. A central aspect of
the pathophysiology of Parkinson's disease is the progressive demise of midbrain dopamine …
the pathophysiology of Parkinson's disease is the progressive demise of midbrain dopamine …
Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance
DG Hernandez, X Reed… - Journal of …, 2016 - Wiley Online Library
Parkinson's disease is a common, progressive neurodegenerative disorder, affecting 3% of
those older than 75 years of age. Clinically, Parkinson's disease (PD) is associated with …
those older than 75 years of age. Clinically, Parkinson's disease (PD) is associated with …
[HTML][HTML] Polyamines in Parkinson's disease: balancing between neurotoxicity and neuroprotection
S Vrijsen, M Houdou, A Cascalho… - Annual Review of …, 2023 - annualreviews.org
The polyamines putrescine, spermidine, and spermine are abundant polycations of vital
importance in mammalian cells. Their cellular levels are tightly regulated by degradation …
importance in mammalian cells. Their cellular levels are tightly regulated by degradation …
Autophagy in neurodegenerative diseases: pathogenesis and therapy
F Guo, X Liu, H Cai, W Le - Brain pathology, 2018 - Wiley Online Library
The most prevalent pathological features of many neurodegenerative diseases are the
aggregation of misfolded proteins and the loss of certain neuronal populations. Autophagy …
aggregation of misfolded proteins and the loss of certain neuronal populations. Autophagy …
Disorders of lysosomal acidification—The emerging role of v-ATPase in aging and neurodegenerative disease
DJ Colacurcio, RA Nixon - Ageing research reviews, 2016 - Elsevier
Autophagy and endocytosis deliver unneeded cellular materials to lysosomes for
degradation. Beyond processing cellular waste, lysosomes release metabolites and ions …
degradation. Beyond processing cellular waste, lysosomes release metabolites and ions …
Extracellular vesicle biomarkers for cognitive impairment in Parkinson's disease
Besides motor symptoms, many individuals with Parkinson's disease develop cognitive
impairment perhaps due to coexisting α-synuclein and Alzheimer's disease pathologies and …
impairment perhaps due to coexisting α-synuclein and Alzheimer's disease pathologies and …